Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 59

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 59
---
 of each of those events and each monthly anniversary thereof
until cured. The amount of liquidated damages payable per monthly period would be equal to 1% of the aggregate purchase price paid by the purchaser, provided, however, the maximum aggregate liquidated damages payable to the purchaser would be 5% of
the aggregate amount paid by such purchaser for the purchaser of such securities in the PIPE Financing.

Some Aadi directors, executive officers and principal stockholders have interests in the PIPE Financing that are different from yours and that may influence them to support or approve the PIPE Financing without regard to your interests.

Certain directors, affiliated funds of directors, and an executive officer of Aadi have interests in the PIPE Financing that are different from, or in addition
to, the interests of Aadi stockholders generally. Certain directors,

- 39 -

affiliated funds of directors, and an executive officer of Aadi entered into the Subscription Agreement in connection with the PIPE Financing, and committed to purchase an aggregate of
4,577,000 shares of common stock and 8,333,000 Pre-Funded Warrants. The PIPE Investors include entities that are related to Casey Castelein, M.D., Anupam Dalal, M.D., Behzad Aghazadeh, Ph.D. and
Baiteng Zhao, who serve on our board of directors, as well as an executive officer for the year ended December 31, 2024, Bryan Ball.

Additionally,
it is expected that Dr. Lennon, Mr. Giacobello and Mr. Ball will continue to serve as executive officers of Aadi following the PIPE Financing and that all members of Aadi’s board of directors will continue to serve thereon following the PIPE
Financing, and that such officers and directors will continue to receive cash and other compensation (including benefits) for such services under applicable plans and arrangements which may be funded with proceeds from the PIPE Financing.

Aadi’s board of directors was aware of and considered those interests, among other matters, in reaching its decision to approve the PIPE Financing and
related matters, including the Subscription Agreement, Registration Rights Agreement and form of Pre-Funded Warrant, and recommend the approval of the PIPE Financing and related matters to Aadi stockholders.
These interests, among other factors, may have influenced the directors and executive officers of Aadi to support or approve the PIPE Financing.

For more
information regarding the interests of Aadi’s directors, executive officers and principal stockholders in the PIPE Financing, please see the sections titled